Expertise in
4
conditions

Eduardo G. Lima

Sao Paulo, SP, BR 
Expertise in
4
conditions
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Eduardo Lima practices in Sao Paulo, Brazil. Mr. Lima is highly rated in 4 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Heart Attack, Angina, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Sao Paulo, SP 01409002, Brazil
Other Locations
Rua Dr. Eneas De Carvalho Aguiar 44, Room 114, Cerqueira Cesar, SP 05403000, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Study to Evaluate the Efficacy and Safety of CardiolRx™ in Patients With COVID-19 and Cardiovascular Disease or Risk Factors A Double-blind, Placebo-controlled Trial
Study to Evaluate the Efficacy and Safety of CardiolRx™ in Patients With COVID-19 and Cardiovascular Disease or Risk Factors A Double-blind, Placebo-controlled Trial
Enrollment Status: Terminated
Publish Date: July 25, 2025
Intervention Type: Drug
Study Drug: Cannabidiol, Pharmaceutically Produced with < 5 ppm THC
Study Phase: Phase 2/Phase 3
A Multicenter, Prospective, Randomized, Clinical Trial Comparing Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
A Multicenter, Prospective, Randomized, Clinical Trial Comparing Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2025
Intervention Type: Other
Study Phase: Not Applicable
Empagliflozin for Prevention of Acute Kidney Injury in Patients With Type 2 Diabetes Mellitus Undergoing Extracorporeal On-pump CABG: The POST-CABGDM Trial
Empagliflozin for Prevention of Acute Kidney Injury in Patients With Type 2 Diabetes Mellitus Undergoing Extracorporeal On-pump CABG: The POST-CABGDM Trial
Enrollment Status: Completed
Publish Date: June 10, 2024
Intervention Type: Drug
Study Drug: Empagliflozin
Study Phase: Phase 4
View 2 Less Clinical Trials

68 Total Publications

Prognostic impact of incomplete revascularization in coronary artery bypass grafting: Association between residual SYNTAX score, magnetic resonance imaging, myocardial injury, and cardiovascular events.
Prognostic impact of incomplete revascularization in coronary artery bypass grafting: Association between residual SYNTAX score, magnetic resonance imaging, myocardial injury, and cardiovascular events.
Journal: Medicine
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lima's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile